Discovery of dihydropyridinone derivative as a covalent EZH2 degrader

被引：2

作者：

Zhou, Bin ^{[1
,2
]}

Wang, Beilei ^{[1
,3
,4
]}

Zou, Fengming ^{[1
,3
,4
]}

Mei, Husheng ^{[1
,2
]}

Liu, Qingwang ^{[1
,3
,4
]}

Qi, Shuang ^{[1
,3
,4
,5
]}

Wang, Wenliang ^{[1
,5
]}

Jin, Rui ^{[1
,3
]}

Wang, Aoli ^{[1
,3
,4
]}

Chen, Yongfei ^{[1
,3
,4
]}

Liu, Feiyang ^{[1
,4
,5
]}

Wang, Wenchao ^{[1
,2
,3
,4
,5
]}

Liu, Jing ^{[1
,2
,3
,4
,5
,6
]}

Liu, Qingsong ^{[1
,2
,3
,4
,5
,6
]}

机构：

[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China

[2] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China

[3] Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China

[4] Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[5] Primary Cell Engn Joint Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[6] Chinese Acad Sci, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 261卷

基金：

中国国家自然科学基金;

关键词：

Enhancer of zeste homolog 2; Covalent inhibitor; EZH2; degrader; HISTONE METHYLTRANSFERASE EZH2; LYSINE; 27; POLYCOMB; INHIBITOR; LYMPHOMA; COMPLEX; DESIGN; HYPERTRIMETHYLATION; IDENTIFICATION; METHYLATION;

D O I：

10.1016/j.ejmech.2023.115825

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

EZH2 is overexpressed in multiple types of cancer and high expression level of EZH2 correlates with poor prognosis. Besides the regulation of H3K27 trimethylation, EZH2 itself regulates its downstream proteins in a PRC2-and methylation-independent way. Starting from an approved EZH2 inhibitor EPZ-6438, we used covalent drug design and medicinal chemistry approaches to discover a novel covalent EZH2 degrader 38, which forms a covalent bond with EZH2 Cys663 and showed strong biochemical activities against EZH2 WT and mutants. Compound 38 exhibited potent antiproliferation effects against both B-cell lymphoma and TNBC cell lines by reducing the levels of H3K27me3 and EZH2. The mass spectrometry, washout and competition experiments confirmed the covalent binding of 38 to EZH2. This study demonstrates that covalent EZH2 degraders could provide an opportunity for the development of promising new drug candidates.

引用

页数：23

共 50 条

[31] Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion
Shi, Lihong
Zhang, Qiangsheng
Zhu, Shirui
Tang, Qing
Chen, Xin
Lan, Rui
Wang, Ningyu
Zhu, Yongxia
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (04) : 831 - 841
[32] Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas
Zhou, Bin
Liang, Xiaofei
Mei, Husheng
Qi, Shuang
Jiang, Zongru
Wang, Aoli
Zou, Fengming
Liu, Qingwang
Liu, Juan
Wang, Wenliang
Hu, Chen
Chen, Yongfei
Wang, Zuowei
Wang, Beilei
Wang, Li
Liu, Jing
Liu, Qingsong
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15170 - 15188
[33] EZH2 Goes Solo
Cavalli, Giacomo
SCIENCE, 2012, 338 (6113) : 1430 - 1431
[34] EZH2 as a potential target in cancer therapy
McCabe, Michael T.
Creasy, Caretha L.
EPIGENOMICS, 2014, 6 (03) : 341 - 351
[35] Targeting EZH2 as cancer therapy Comment
Hanaki, Shunsuke
Shimada, Midori
JOURNAL OF BIOCHEMISTRY, 2021, 170 (01) : 1 - 4
[36] EZH2: an emerging role in melanoma biology and strategies for targeted therapy
Tiffen, Jessamy
Gallagher, Stuart J.
Hersey, Peter
PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (01) : 21 - 30
[37] The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
Wang, Ying
Bui, Tien
Zhang, Yi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (06) : 837 - 845
[38] EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Li, Boheng
Chng, Wee-Joo
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
[39] Loss of Ezh2 function remodels the DNA replication initiation landscape
Prorok, Paulina
Forouzanfar, Faezeh
Murugarren, Nerea
Peiffer, Isabelle
Charton, Romain
Akerman, Ildem
Mechali, Marcel
CELL REPORTS, 2023, 42 (04):
[40] Inhibition of EZH2 transactivation function sensitizes solid tumors to stress
Liao, Yiji
Chen, Chen-Hao
Xiao, Tengfei
Avalos, Barbara de la Pena
Dray, Eloise, V
Cai, Changmeng
Gao, Shuai
Shah, Neel
Zhang, Zhao
Feit, Avery
Xue, Pengya
Liu, Zhijie
Yang, Mei
Lee, Ji Hoon
Xu, Han
Li, Wei
Mei, Shenglin
Pierre, Roodolph S.
Shu, Shaokun
Fei, Teng
Duarte, Melissa
Zhao, Jin
Bradner, James E.
Polyak, Kornelia
Kantoff, Philip W.
Long, Henry
Balk, Steven P.
Liu, X. Shirley
Brown, Myles
Xu, Kexin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (03)

← 1 2 3 4 5 →